AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) revenue breakdown overview

AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) revenue for the last year amounted to 170.00 k USD, the most of which — 170.00 k USD — came from its highest performing source at the moment, Ampligen and Other Drugs, the year earlier bringing 202.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) 170.00 k USD, and the year before that — 202.00 k USD.